¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"delayed side tone test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • lethal titer test
    Ä¡»ç¿ª°¡°Ë»ç
  • litmus test
    ¸®Æ®¸Ó½º½ÃÇè, ¸®Æ®¸Ó½º°Ë»ç
  • liver function test
    °£±â´É°Ë»ç
  • migration inhibition test
    À̵¿¾ïÁ¦°Ë»ç, À̵¿ÀúÁö°Ë»ç
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • monaural loudness balance test
    ´ÜÀÌÀ½ÆòÇü°Ë»ç
  • multiple sleep latency test
    ¼ö¸éÀẹ±â¹Ýº¹°Ë»ç
  • Mantoux test
    ¸ÁÅõ°Ë»ç
  • metacholine challenge test
    ¸ÞŸÄݸ°À¯¹ß°Ë»ç
  • neutralization test
    ÁßÈ­°Ë»ç
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • nonparametric test
    ºñÁöÇ¥°ËÁ¤
  • nonstress test
    ºñ¼öÃà°Ë»ç
  • occult blood test
    ÀáÇ÷°Ë»ç
  • one-tail test
    ´ÜÃø°ËÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • depressor test
    °¨¾Ð½ÃÇè
  • dermatophyte test medium
    ÇǺλç»ó±Õ½ÃÇè¹èÁö
  • dermographic test
    ÇǺα׸²°Ë»ç
  • developing test
    Àü°³½ÃÇè
  • deviation test
    Ä¡¿ìħ°Ë»ç
  • difference limen test
    ÆÇº°¿ªÄ¡°Ë»ç
  • dilution test
    Èñ¼®°Ë»ç
  • direct agglutination test
    Á÷Á¢ÀÀÁý°Ë»ç
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°°Ë»ç
  • disc sensitivity test
    ¿øÆÇ¹Î°¨°Ë»ç
  • discrimination test
    ¾îÀ½ÆÇº°°Ë»ç
  • dot blot test
    Á¡Àû°Ë»ç, ¾ó·èÁ¡°Ë»ç
  • double blind test
    ÀÌÁ߸Ͱ˻ç
  • duochrome test
    µÎ°¡Áö»ö±¼Àý°Ë»ç
  • dye test
    »ö¼Ò°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Western blot test
    ¿þ½ºÅϺí·Ô½ÃÇè
  • Westgard quality control test
    ¿þ½ºÆ®°¡µåÁ¤µµ°ü¸®°Ë»ç¹ý
  • Widal test
    À§´Þ½ÃÇè.
  • Widal test
    À§´Þ½ÃÇè
  • Winn test
    À© Á¾¾ç¸é¿ªÁßÈ­½ÃÇè
  • Worth 4-dot test
    ¿öÆ®4µî°Ë»ç
  • Zondek-Aschheim test
    Á¸µ¦-¾Æ½¬ÇÏÀÓ ½ÃÇè
  • abrasion test
    ¸¶¸ê½ÃÇè(بØþãËúÐ).
  • absorption test
    Èí¼ö½ÃÇè
  • absorption test, agglutinin
    ÀÀÁý¼Ò Èí¼ö½ÃÇè
  • acceptance test
    Àμö°Ë»ç
  • acetest tablet test
    ¾Æ¼¼Å×½ºÆ®Á¤(ïü)½ÃÇè
  • achievement test
    ¼öµæ´É·Â(µµ)°Ë»ç(áóÔðÒöæ³öôËþÞÛ).
  • acid challenge test
    »ê Åõ¿©½ÃÇè
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • acceptance test
    Àμö°Ë»ç
  • acetest tablet test
    ¾Æ¼¼Å×½ºÆ®Á¤(ïü)½ÃÇè
  • achievement test
    ¼öµæ´É·Â(µµ)°Ë»ç(áóÔðÒöæ³öôËþÞÛ).
  • acid challenge test
    »ê Åõ¿©½ÃÇè
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè(ß«àõûùúìôèãËúÐ).
  • acoustic reflex(test)
    À½Çâ¹Ý»ç, À̼Ұñ±Ù¹Ý»ç(°Ë»ç)
  • active force generation test
    ±Ù·Â°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø½ÃÇè
  • adsorption test
    ÈíÂø½ÃÇè.
  • afterimage test
    ÀÜ»ó°Ë»ç
  • afterimage transfer test
    ÀÜ»óÀüÀ̰˻ç
  • agar gel precipitin inhibition test
    ÇÑõ°Öħ°­¼Ò ÀúÁö½ÃÇè(¡­ ˽áÈðæò­ãËúÐ).
  • agglutination inhibition test
    ÀÀÁý¾ïÁ¦½ÃÇè(¡­åäð¤ãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
DPC delayed primary closure; desaturated phosphatidylcholine; diethylpyrocarbonate; direct patient care;...
DPS delayed primary suture; descending perineum syndrome; dimethylpolysiloxane; dysesthetic pain syndrom...
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
DSHR delayed skin hypersensitivity reaction
DSP decreased sensory perception; delayed sleep phase; desmoplakin; dibasic sodium phosphate; digital si...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
OPIDN organophosphorous compound-induced delayed neurotoxicity
OPIDN organophosphorus induced delayed neurotoxicity
(13)C-UBT 13)C-urea breath test
UBT 13)C-urea breath test
ABT 13C]-aminopyrine breath test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • copper sulfate test
    Ȳ»ê µ¿ °Ë»ç
  • cortisone glucose tolerance test
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇÏ ½ÃÇè
  • Cosyntropin stimulation test
    ÄÚ½ÅÆ®·ÎÇÉ ÀÚ±Ø ½ÃÇè
  • cover-uncover test
    Ä¿¹ö-¾ðÄ¿¹ö ½ÃÇè
  • Crafts' test
    Å©¶øÆ® ½ÃÇè
  • Cramptom's test
    Å©·¥ÇÁÅæ ½ÃÇè
  • creatinine clearance test
    Å©ºñ¾ÆÆ¼´Ñ Á¦°Å ½ÃÇè
  • Cuboni's test
    Äíº¸´Ï ½ÃÇè
  • cuff test
    ¿ïÇ÷´ë ½ÃÇè, Ä¿ÇÁ ½ÃÇè
  • Cuignet's test
    ÄûÀÌ³× ½ÃÇè
  • cyanide-nitroprusside test
    ½Ã¾ÈÈ­-³ªÀÌÆ®·ÎǪ¸£»çÀÌµå °Ë»ç
  • cysteine test
    ½Ã½ºÆ¾ ½ÃÇè
  • cytochrome oxidase test
    »çÀÌÅäÅ©·Ò »êÈ­ È¿¼Ò °Ë»ç
  • cytogenetic test
    ¼¼Æ÷ À¯Àü °Ë»ç
  • Cytronbergs test
    ½ÃÆ®·Ðº£¸£Å© ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
Rapoport test A differential ureteral catheterization test used to evaluate suspected renovascular hypertension; urine specimens from each kidney are obtained by bilateral ureteral catheterization, and the tubular rejection fraction ratio is determined by measuring concentrations of sodium and creatinine in the urine from each kidney.
(05 Mar 2000)
Mantel-Haenszel test A summary chi-square test developed by Mantel and Haenszel for stratified data, used when controlling for confounding.
(05 Mar 2000)
Rayleigh test A ratio of red to green required by each observer to match spectral yellow.
Synonym: Rayleigh test.
(05 Mar 2000)
parallax test Measurement of the deviation in strabismus by the alternate cover test combined with neutralization of the deviation using prisms.
(05 Mar 2000)
Mantoux test <investigation> Test for tuberculin reactivity in which tuberculin PPD (purified protein derivative) is injected intracutaneously. The injection site is examined after 2-3 days, a positive reaction, indicating current or previous infection with Mycobacterium tuberculosis (in an uninoculated individual), is an oedomatous and reddened area caused by T-cell reactivity.
(18 Nov 1997)
parametric test A statistical test that depends on an assumption about the distribution of the data, e.g., that the data are normally distributed.
(05 Mar 2000)
genetic complementation test A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.
(12 Dec 1998)
Geraghty's test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
Marshall-Marchetti test Manual deviation of bladder neck during strain or cough to ascertain presence of stress urinary incontinence.
Synonym: Bonney test, Marshall-Marchetti test.
(05 Mar 2000)
Marshall test Manual deviation of bladder neck during strain or cough to ascertain presence of stress urinary incontinence.
Synonym: Bonney test, Marshall-Marchetti test.
(05 Mar 2000)
Gerhardt's test for acetoacetic acid In fresh urine a red colour develops upon addition of FeCl3; no colour develops if the urine has first been boiled; this test has low specificity and sensitivity.
Synonym: Gerhardt's reaction.
(05 Mar 2000)
Gerhardt's test for urobilin in the urine The urobilin is extracted with chloroform and then treated with iodine and potassium hydrate, a fluorescent green colour being produced.
(05 Mar 2000)
carotid sinus test Stimulation of one carotid sinus (never both) to produce reflex effects that may slow the heart, reduce the systolic blood pressure or both for diagnostic or, in the case of certain arrhythmias, therapeutic purposes.
(05 Mar 2000)
germ tube test A test for the identification of Candida albicans; after a 3-hr incubation in serum, an inoculum of Candida develops tubelike appendages.
(05 Mar 2000)
carrier test A test designed to detect carriers of a gene for recessive genetic disorder. For example, carrier testing is done for sickle cell trait, thalassaemia trait, and the Tay-Sachs gene.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á